Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influenza vaccine immune response in MGUS patients
2010-022693-14Phase 4Active
- Sponsor
- University Medical Center Groningen
- Start
- Sep 2010
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
Phase 4 trial of influenza vaccine in monoclonal gammopathy of undetermined significance (MGUS) and influenza (2 arms), sponsored by University Medical Center Groningen. Primary endpoint: Haemagglutinin inhibition test response. Started Sep 2010; status: active.
02
Drugs
influenza vaccine
03
Conditions
monoclonal gammopathy of undetermined significance (MGUS)influenza
Beyond the preview
Go deeper on 2010-022693-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022693-14.